BAN-BAN Interference Performance Analysis with DSUWB

To ban or not to ban?

The past four years have seen a steady increase in the number of companies that offer direct-to-consumer (DTC) genetic testing services and in the number of such tests for genetic risk factors, including a wide range of diseases and other non-disease-related traits. These companies sell their tests outside the traditional healthcare setting and often do not involve healthcare professionals for ...

Bromoxynil Ban

a potent new luteinising hormone-releasing hormone agonist Zoladex (ICI 118630) in a phase I clinical trial. On progression of disease 26 patients have undergone therapeutic oophorectomy. We present the clinical and endocrinological responses to treatment in 45 assessable patients. The response rate to Zoladex in this series was 31% and the ER status of the primary tumour was predictive of a re...

To ban or not to ban? - that is the question.

The Descent of BAN

The famous BAN paper [3] determined the research agenda of security-protocol verification for nearly a decade. Many others had worked on verifying security protocols, and the problem appeared to be intractable. The real-world systems were too complicated; too many different things could go wrong; the formal treatments were unusable. The BAN logic was abstract, formalizing intuitive notions dire...

Vending machines in schools: to ban or not to ban?

hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Annals of Allergy 1989; 63: 102–6. 4 Chandra R. Five-year follow-up of high risk infants with family history of allergy who were exclusively breastfed or fed partial whey hydrolysate, soy and conventional cow’s milk formulas. Journal of Pediatriatric Gastroenterology and Nutrition 1997; 24: ...